Blood pressure regulation by endocannabinoids and their receptors

Neuropharmacology

Volumn 48, Issue 8 SPEC. ISS., 2005, Pages 1130-1138

  Pacher, Pál ^a   Bátkai, Sándor ^a   Kunos, George ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Cannabinoids; Cardiac contractility; Hemodynamics; Hypertension

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; ANTIHYPERTENSIVE AGENT; CALCITONIN; CANNABINOID RECEPTOR; CANNABINOL DERIVATIVE; CAPSAZEPINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DELTA N TETRAHYDROCANNABINOL; DEXANABINOL; ENDOCANNABINOID; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NORADRENALIN; OMDM 2; RIMONABANT; RUTHENIUM RED; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

BLOOD PRESSURE REGULATION; CARDIOGENIC SHOCK; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEMORRHAGIC SHOCK; HYPERTENSION; HYPOTENSION; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; VASODILATATION;

EID: 19444369394     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.12.005     Document Type: Article

References (57)

1. M.D. Adams, L.D. Chait, and J.T. Earnhardt Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat Br. J. Pharmacol. 56 1 1976 43 48
2. M.D. Adams, J.T. Earnhardt, B.R. Martin, L.S. Harris, W.L. Dewey, and R.K. Razdan A cannabinoid with cardiovascular activity but no overt behavioral effects Experientia 33 1977 1204 1205
3. R.A. Archer The cannabinoids: therapeutic potentials Annu. Rev. Med. Chem. 9 1974 253 259
4. S. Bátkai, Z. Járai, J.A. Wagner, S.K. Goparaju, K. Varga, J. Liu, L. Wang, F. Mirshahi, A.D. Khanolkar, A. Makriyannis, R. Urbascheck, N. Garcia Jr., A.J. Sanyal, and G. Kunos Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis Nat. Med. 7 2001 827 832
5. 2 receptors Am. J. Physiol. 287 2 2004 H595 H600
6. 1 receptors regulate cardiovascular function in hypertension Circulation 110 14 2004 1996 2002
7. + current J. Biol. Chem. 278 46 2003 46188 46194
8. M.K. Birmingham Reduction by 9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands Br. J. Pharmacol. 48 1 1973 169 171
9. A. Bonz, M. Laser, S. Kullmer, S. Kniesch, J. Babin-Ebell, V. Popp, G. Ertl, and J.A. Wagner Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle J. Cardiovasc. Pharmacol. 41 2003 657 664
10. A. Calignano, G. La Rana, M. Beltramo, A. Makriyannis, and D. Piomelli Potentiation of anandamide hypotension by the transport inhibitor, AM404 Eur. J. Pharmacol. 337 1 1997 R1 R2
11. W.J. Crawford, and J.C. Merritt Effects of tetrahydrocannabinol on arterial and intraocular hypertension Int. J. Clin. Pharmacol. Biopharm. 17 5 1979 191 196
12. W.R. Ford, S.A. Honan, R. White, and C.R. Hiley Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts Br. J. Pharmacol. 135 2002 1191 1198
13. S.J. Gatley, R. Lan, B. Pyatt, A.N. Gifford, N.D. Volkow, and A. Makriyannis Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors Life Sci. 61 1997 PL191 PL197
14. 2+ channel current Am. J. Physiol. 266 1999 H2085 H2093
15. C.R. Hiley, and W.R. Ford Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? Br. J. Pharmacol. 138 7 2003 1183 1184
16. C.R. Hiley, and W.R. Ford Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling Biol. Rev. Camb. Philos. Soc. 79 1 2004 187 205
17. C.J. Hillard Endocannabinoids and vascular function J. Pharmacol. Exp. Ther. 294 2000 27 32
18. W.S. Ho, and C.R. Hiley Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery Br. J. Pharmacol. 138 2003 1320 1332
19. E.J. Ishac, L. Jiang, K.D. Lake, K. Varga, M.E. Abood, and G. Kunos Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves Br. J. Pharmacol. 118 1996 2023 2028
20. Z. Járai, J.A. Wagner, K. Varga, K.D. Lake, D.R. Compton, B.R. Martin, A.M. Zimmer, T.I. Bonner, N.E. Buckley, E. Mezey, R.K. Razdan, A. Zimmer, and G. Kunos Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc. Natl Acad. Sci. U.S.A. 96 1999 14136 14141
21. S. Kathuria, S. Gaetani, D. Fegley, F. Valino, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. La Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, and D. Piomelli Modulation of anxiety through blockade of anandamide hydrolysis Nat. Med. 9 2003 76 81
22. 9- tetrahydrocannabinol Arch. Int. Pharmacodyn. Ther. 233 1978 76 81
23. G. Kunos, S. Bátkai, L. Offertáler, F. Mo, J. Liu, J. Karcher, and J. Harvey-White The quest for a vascular endothelial cannabinoids receptor Chem. Phys. Lipids 121 2002 45 56
24. G. Kunos, Z. Járai, S. Bátkai, S.K. Goparaju, E.J. Ishac, J. Liu, L. Wang, and J.A. Wagner Endocannabinoids as cardiovascular modulators Chem. Phys. Lipids 108 2000 159 168
25. K.D. Lake, D.R. Compton, K. Varga, B.R. Martin, and G. Kunos Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors J. Pharmacol. Exp. Ther. 281 1997 1030 1037
26. K.D. Lake, B.R. Martin, G. Kunos, and K. Varga Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats Hypertension 29 1997 1204 1210
27. C. Ledent, O. Valverde, G. Cossu, F. Petitet, J.F. Aubert, F. Beslot, G.A. Bohme, A. Imperato, T. Pedrazzini, B.P. Roques, G. Vassart, W. Fratta, and M. Parmentier Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 283 1999 401 404
28. J. Li, N.E. Kaminski, and D.H. Wang Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor Hypertension 41 2003 757 762
29. J. Liu, S. Bátkai, P. Pacher, J. Harvey-White, J.A. Wagner, B.F. Cravatt, B. Gao, and G. Kunos LPS induces anandamide synthesis in macrophages via CD14/MAPK/PI3K/NF-κB independently of platelet activating factor J. Biol. Chem. 278 2003 45034 45039
30. J. Liu, B. Gao, F. Mirshahi, A.J. Sanyal, A.D. Khanolkar, A. Makriyannis, and G. Kunos Functional CB1 cannabinoid receptors in human vascular endothelial cells Biochem. J. 346 2000 835 840
31. A.B. Lumsden, J.M. Henderson, and M.H. Kutner Endotoxin levels measured by a chromatographic assay in portal, hepatic and peripheral blood in patients with cirrhosis Hepatology 8 1988 232 236
32. B. Malinowska, G. Godlewski, B. Boucher, and E. Schlicker Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat Naunyn Schmiedebergs Arch. Pharmacol. 356 1997 197 202
33. B. Malinowska, G. Kwolek, and M. Gothert Anandamide and methanandamide induce both vanilloid VR1- and cannabinoids CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats Naunyn Schmiedebergs Arch. Pharmacol. 364 2001 562 569
34. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, C.A. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
35. R. Mechoulam, E. Fride, and V. Di Marzo Endocannabionoids Eur. J. Pharmacol. 359 1998 1 18
36. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
37. N. Niederhoffer, and B. Szabo Cannabinoids cause central sympathoexcitation and bradycardia in rabbits J. Pharmacol. Exp. Ther. 294 2000 707 713
38. L. Offertáler, F.M. Mo, S. Bátkai, J. Liu, M. Begg, R.K. Razdan, B.R. Martin, R.D. Bukoski, and G. Kunos Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor Mol. Pharmacol. 63 2003 699 705
39. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA) Br. J. Pharmacol. 141 5 2004 803 812
40. P. Pacher, S. Bátkai, and G. Kunos Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice J. Physiol. (Lond.) 558 2004 647 657
41. P. Pacher, L. Liaudet, P. Bai, J.G. Mabley, P.M. Kaminski, L. Virág, A. Deb, E. Szabo, Z. Ungvári, M.S. Wolin, J.T. Groves, and C. Szabo Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction Circulation 107 2003 896 904
42. V. Ralevic, D.A. Kendall, M.D. Randall, and D. Smart Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function Life Sci. 71 2002 2577 2594
43. M.D. Randall, D. Harris, D.A. Kendall, and V. Ralevic Cardiovascular effects of cannabinoids Pharmacol. Ther. 95 2002 191 202
44. J. Ros, J. Claria, J. To-Figueras, A. Planaguma, P. Cejudo-Martin, G. Fernandez-Varo, R. Martin-Ruiz, V. Arroyo, F. Rivera, J. Rodes, and W. Jimenez Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat Gastroenterology 122 2002 85 93
45. E.A. Stein, S.A. Fuller, W.S. Edgemond, and W.B. Campbell Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat Br. J. Pharmacol. 119 1996 107 114
46. K. Varga, K. Lake, B.R. Martin, and G. Kunos Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide Eur. J. Pharmacol. 278 1995 279 283
47. K. Varga, K.D. Lake, D. Huangfu, P.G. Guyenet, and G. Kunos Mechanism of the hypotensive action of anandamide in anesthetized rats Hypertension 28 1996 682 686
48. K. Varga, J.A. Wagner, D.T. Bridgen, and G. Kunos Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension FASEB J. 12 1998 1035 1044
49. D.R. Varma, and D. Goldbaum Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats J. Pharm. Pharmacol. 27 10 1975 790 791
50. J.A. Wagner, K. Hu, J. Bauersachs, J. Karcher, M. Wiesler, S.K. Goparaju, G. Kunos, and G. Ertl Endogenous cannabinoids mediate hypotension after experimental myocardial infarction J. Am. Coll. Cardiol. 38 2001 2048 2054
51. J.A. Wagner, K. Hu, J. Karcher, J. Bauersachs, A. Schafer, M. Laser, H. Han, and G. Ertl CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction Br. J. Pharmacol. 138 7 2003 1251 1258
52. J.A. Wagner, Z. Járai, S. Bátkai, and G. Kunos Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors Eur. J. Pharmacol. 423 2001 203 210
53. J.A. Wagner, K. Varga, E.F. Ellis, B.A. Rzigalinski, B.R. Martin, and G. Kunos Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock Nature 390 1997 518 521
54. L. Walter, and N. Stella Cannabinoids and neuroinflammation Br. J. Pharmacol. 141 5 2004 775 785
55. Y. Wang, Y. Liu, Y. Ito, T. Hashiguchi, I. Kitajima, M. Yamakuchi, H. Shimizu, S. Matsuo, H. Imaizumi, and I. Maruyama Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock Anal. Biochem. 294 2001 73 82
56. H.E. Zaugg, and J. Kyncl New antihypertensive cannabinoids J. Med. Chem. 26 2 1983 214 217
57. P.M. Zygmunt, J. Petersson, D.A. Andersson, H.-H. Chuang, M. Sorgard, V. Di Marzo, D. Julius, and E.D. Högestätt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457